• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    University of Rochester Medical Center Boosts Diagnostic Accuracy and Workflow Efficiency with Butterfly Network's Enterprise Ultrasound Solution

    9/17/24 8:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email
    • URMC increased ultrasound charge capture by 116% following system-wide deployment of Butterfly Network devices and Compass™ workflow software.
    • URMC's implementation results published on September 16, 2024 in the Journal of Clinical Imaging Science.

    Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today published a case study highlighting the positive impact of University of Rochester Medical Center's (URMC) transformative, system-wide deployment of Butterfly's point-of-care ultrasound (POCUS) devices and enterprise ultrasound platform, Compass™. The results are backed by an academic paper published yesterday, September 16, 2024, in the Journal of Clinical Imaging Science.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917669860/en/

    URMC Primary Care training on Butterfly devices. June 2022 (Photo: Business Wire)

    URMC Primary Care training on Butterfly devices. June 2022 (Photo: Business Wire)

    In early 2021, URMC partnered with Butterfly to launch an enterprise-wide ultrasound program designed to improve access to imaging, enhance clinical workflows, and drive value for both patients and providers. To date, URMC has deployed 862 Butterfly devices across 64 academic departments and clinical programs, integrated with Butterfly's Compass™ workflow software. URMC plans to scale the program to 2,500 devices by 2026. This innovative implementation has resulted in a 116% increase in ultrasound charge capture across the health system.

    Since 2022, nearly 50,000 scanning sessions have been completed, generating over 175,000 images and 15,524 finalized reports. This growth has fueled a 74% increase in scanning sessions in 2023, a 147% rise in studies uploaded from Butterfly devices and a 1,782% jump in images uploaded from non-Butterfly devices. These achievements have contributed to earlier diagnoses, such as detecting cholecystitis, abscesses and bladder masses, significantly improving patient outcomes while reducing emergency visits.

    "Our phased deployment of Butterfly devices and Compass software has yielded impressive clinical and administrative results at URMC to date. URMC is proud to be at the forefront of the wide-scale deployment of innovative point-of-care ultrasound technology, and we believe it shows promise as the right care model for the medical community at large," commented Michael F. Rotondo, MD, Chief Executive Officer of the University of Rochester Medical Faculty Group, Senior Vice President of URMC.

    "I'm inspired by Dr. Rotondo's visionary leadership in driving the system-wide deployment of point-of-care ultrasound across URMC. Patients are receiving care earlier, doctors are empowered to make a greater impact, and care is becoming more efficient – proving a compelling return on investment," said Joseph DeVivo, president, CEO, and board chairman of Butterfly Network. "Health system leaders are recognizing the power of POCUS as a comprehensive solution. Thousands of studies confirm early diagnoses across venues annually, yet many go unrecorded and unreimbursed, resulting in millions of dollars in unbilled ultrasound scans. Individual providers are already onboard; tens of thousands have purchased their own Butterfly devices knowing they improve patient care. Now it's time for health system C-suites to work with those doctors to build an enterprise-wide POCUS program. This means committing to education, deploying Butterfly's Compass Software, and integrating Butterfly iQ3 across their institution to deliver state-of-the-art early diagnosis and unlock these strong clinical and financial results."

    To read the full case study visit: ​​https://butterflynetwork.com/case-studies-urmc. For more information on Butterfly Network, visit www.butterflynetwork.com.

    For more information on the University of Rochester Medical Center, visit https://www.urmc.rochester.edu.

    About Butterfly Network

    Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore's Law, to launch its second-generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME's Best Inventions, Fast Company's World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: www.butterflynetwork.com/choose-your-country.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240917669860/en/

    Get the next $BFLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    8/1/2025Outperform → Perform
    Oppenheimer
    7/1/2025$3.00Buy
    Craig Hallum
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings

    $BFLY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Butterfly Network Inc.

    SCHEDULE 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    3/26/26 4:40:28 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.

    SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    3/17/26 4:20:28 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 144 filed by Butterfly Network Inc.

    144 - Butterfly Network, Inc. (0001804176) (Subject)

    3/5/26 4:42:18 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Phanstiel S. Louise bought $571,160 worth of shares (185,261 units at $3.08) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/17/25 4:10:13 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $64,471 worth of shares (21,370 units at $3.02) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/15/25 6:20:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $4,652,773 worth of shares (1,558,541 units at $2.99) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/5/25 5:40:49 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    William Blair initiated coverage on Butterfly Network

    William Blair initiated coverage of Butterfly Network with a rating of Outperform

    3/17/25 7:23:53 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $BFLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

    Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

    3/10/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes

    Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 3, 2026 /CNW/ -- USANewsGroup.com News Commentary -- AI is making its way through the halls of our entire medical system, and the implementation is accelerating at a great pace. The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR[1]. Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand cardiac platforms that prove economic value alongside clinical accuracy[2]. Companies like VentriPoint Diagnostics (TSXV:VPT) (OTCPK: VPTDF), Butterfly Network (NYSE:BFLY), Tempus AI (NASDAQ:TEM), RadNet (NASDAQ:RDNT), and GE HealthCare (NASDAQ:GEHC) are conv

    3/3/26 12:19:00 PM ET
    $BFLY
    $GEHC
    $RDNT
    Medical Electronics
    Health Care
    Medical Specialities
    Computer Software: Programming Data Processing

    Butterfly Network Reports Fourth Quarter 2025 Financial Results

    Delivered Record Annual and Quarterly Revenue Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's Presiden

    2/26/26 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    President & CEO Devivo Joseph sold $1,788,291 worth of shares (482,149 units at $3.71), decreasing direct ownership by 6% to 8,030,899 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/6/26 4:05:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    EVP, CFO Doherty John N. was granted 274,953 shares, increasing direct ownership by 22% to 1,509,641 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/4/26 4:13:21 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Chief Technology Officer Ku Victor was granted 287,326 shares, increasing direct ownership by 35% to 1,099,288 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/4/26 4:12:16 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Leadership Updates

    Live Leadership Updates

    View All

    Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

    Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

    3/10/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints John Doherty as Chief Financial Officer

    Seasoned finance leader brings over 25 years of leadership experience driving growth and transformation Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025. Doherty has more than 25 years of global financial leadership experience, guiding public and private companies through major growth, transformation, and strategic transactions across the technology and telecommunications industries. Doherty joins Butterfly from Kaltura, a global leader in video SaaS solut

    10/9/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Victor Ku as Chief Technology Officer

    Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced the appointment of Victor Ku as Senior Vice President and Chief Technology Officer (CTO). Victor will join the company in late September and will be responsible for leading Butterfly's global technology strategy, product development, and innovation roadmap. "Victor's deep expertise in semiconductor-based imaging and his proven ability to scale global product development make him a perfect fit for Butterfly's next phase of growth," said Joseph DeVivo, President and CEO of Butterfly Network. "His leadership will b

    9/9/25 8:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Financials

    Live finance-specific insights

    View All

    Butterfly Network Reports Fourth Quarter 2025 Financial Results

    Delivered Record Annual and Quarterly Revenue Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's Presiden

    2/26/26 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on February 26 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

    2/3/26 8:01:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Reports Third Quarter 2025 Financial Results

    Delivered quarterly revenue of $21.5 million in Q3, representing 5% YoY growth. Reduced quarterly cash burn to $3.9 million, a new record low for quarterly cash usage. Reaffirmed full year revenue guidance and narrowed adjusted EBITDA guidance. Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "We view this quarter as a period of foundational

    10/31/25 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    9/3/24 7:10:06 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    8/30/24 4:05:41 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by Butterfly Network Inc.

    SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    7/8/24 4:32:42 PM ET
    $BFLY
    Medical Electronics
    Health Care